May 29, 2019 — QT Ultrasound recently showcased its advanced ultrasound technology at the Acoustical Society of America ...
A clinical study presented at the American Thoracic Society (ATS) 2019 annual meeting, May 17-22 in Dallas, described the use of Konica Minolta’s Dynamic Digital Radiography (DDR) technology in the assessment of undifferentiated dyspnea.
Out of more than 7 million current and former heavy smokers, only 1.9 percent were screened for lung cancer in 2016 despite screening recommendations, according to a new analysis. These numbers come despite U.S. Preventive Services Task Force (USPSTF) and American Society of Clinical Oncology (ASCO) screening recommendations.
Radiology plays a crucial role in diagnosing — from guiding patients into the right treatment plans through follow-up ...
Leica Biosystems has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX System for clinical diagnosis in the U.S.
While radiation therapy as a discipline is well into maturity, new technology advances continue to drive the field ...
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at ...
Many healthcare organizations are turning to the public cloud to be more flexible, agile and scalable when deploying and ...
A new clinical study shows that Natera's Signatera test identified colorectal cancer recurrence up to 16.5 months earlier than radiologic imaging by detecting traces of tumor DNA in the blood after surgery. The test also identified patients most likely to relapse, both before and after chemotherapy.1 Results were published in the May issue of JAMA Oncology.
Philips and Alverno Laboratories, a provider of high-quality diagnostic testing services, announced that Alverno will fully implement digital pathology in its clinical laboratories. The laboratory network will use Philips IntelliSite Pathology Solution to assess and diagnose all clinical histology cases digitally, instead of using a microscope, with the aim of improving laboratory efficiency, quality and patient safety.
The Clario SmartWorklist intelligently manages picture archiving and communication system (PACS) reading workflow by automatically organizing each radiologist’s daily reading tasks according to their credentials, subspecialty, workload, availability, and more.
From sharing patient information between physicians to improving the speed and efficacy of treatment by making faster ...
Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more precise and personalized. This work will be a critical component of a new interdisciplinary research project funded with $1.4 million from the National Institutes of Health (NIH) that seeks to improve radiation therapy for high-risk prostate cancer patients.
Clinical metal artifact reduction sequence (MARS) magnetic resonance imaging (MRI) protocols at 3 Tesla (3T) on hip arthroplasty implants pose minimal risk of thermal injury, according to a recent study. The findings were presented at the American Roentgen Ray Society (ARRS) 2019 Annual Meeting, May 5-10 in Honolulu.
Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (NPs) using multimodal positron emission tomography/magnetic resonance imaging (PET/MRI) offers promising improvements in imaging capabilities. The paper is published in the American Chemical Society journal ACS Omega.
Postpandemic staffing shortages and increased volumes require radiologists to do more with less, exacerbating burnout ...
ControlRad Inc. announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its ControlRad Trace and the company has initiated its commercial launch. The ControlRad Trace is the only technology, according to the company, that can be integrated into existing mobile C-arms to reduce radiation in any fluoroscopic imaging procedure.
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of experiencing side-effects from their radiation therapy, while cure rates are almost identical between the two groups. Researchers in the Perelman School of Medicine at the University of Pennsylvania conducted the largest review of its kind to evaluate whether or not patients undergoing radiation therapy at the same time as chemotherapy experienced serious adverse events within 90 days. They will present their findings at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31-June 4 in Chicago (Abstract #6521).
Research has demonstrated use of Volpara Solutions' VolparaDensity software in combination with the Tyrer-Cuzick Breast Cancer Risk Evaluation Tool improves breast cancer risk stratification. The research suggests VolparaDensity could be used to help guide personalized medicine through risk-adapted screening.
Santa Casa de Misericordia has selected Carestream to replace its legacy diagnostic workflow technology across all seven of its hospitals in Porto Alegre, the capital and largest city of the Brazilian state of Rio Grande do Sul.
Philips announced that Philips Lumify, a point-of-care ultrasound device, has earned the U.S. Army Airworthiness Certification after passing a series of rigorous military tests. This certification now allows Philips Lumify to be added to an Army medic’s bag in a helicopter so they can immediately evaluate if a solider has a life-threatening injury, such as internal bleeding, a broken rib or a bullet wound to critical organs. The Airworthiness Certification also allows medics using Philips Lumify to facilitate continuity of care between the battlefield, aircraft, ambulance and emergency room.
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new ...
This is a Philips Brilliance computed tomography (CT) scanner used by Henry Ford Hospital’s radiation oncology ...
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August and will be available as the second part of the Accipio ICH Platform. Accipio Ax will provide new tools to support clinical assessment of intracranial hemorrhage (ICH). Radiology departments, emergency room and neuroradiology teams across the U.S. and the EU will soon be able to access a comprehensive solution for ICH triage through workflow prioritization and slice-level preview. Accipio Ax includes the exclusive Accipio Ax SliceMap, an integrated view which guides clinicians rapidly to computed tomography (CT) slices with suspected ICH without leaving their picture archiving and communication system (PACS) viewer.